COMP <GO>
ZUMZ vs PG // DIVIDEND YIELD & FCF PAYOUT SAFETY
Zumiez Inc. (NASDAQ) VS. Procter & Gamble Company (NYSE) • 15-METRIC TALLY: ZUMZ 5
— PG 8
▲ DIVIDEND YIELD & FCF PAYOUT SAFETY LEADER: PG
LAST: $15.17 (+0.33%) • MKT CAP: $231.8M
dividend-safety
0.00%
LAST: $161.57 (+0.61%) • MKT CAP: $372.21B
dividend-safety
2.65%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ZUMZ VS. PG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ZUMZ | PG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 35.80% | 51.20% | -15.40 | PG | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 6.90% | 25.40% | -18.50 | PG | /roic <GO> |
| EV/EBITDA & P/E Valuation | 4.4x | 16.2x | -11.80 | ZUMZ | /valuation <GO> |
| Free Cash Flow Yield | 18.30% | 3.77% | +14.53 | ZUMZ | /fcf-yield <GO> |
| Operating Margin | 1.80% | 24.30% | -22.50 | PG | /operating-margins <GO> |
| Net Profit Margin | 1.40% | 19.00% | -17.60 | PG | /net-margins <GO> |
| Revenue Growth (YoY) | 4.50% | 0.30% | +4.20 | ZUMZ | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety ACTIVE | 0.00% | 2.65% | -2.65 | PG | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.55 | 5.59 | -3.04 | PG | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | ZUMZ | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 56.7 | 60.3 | -3.60 | PG | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.87 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 16.1x | 21.7x | -5.60 | ZUMZ | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $231.8M | $372.21B | -$371.98B | PG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ZUMZ REV | PG REV | ZUMZ GROSS % | PG GROSS % | ZUMZ FCF | PG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $929.1M | $84.28B | 35.8% | 51.2% | $42.4M | $14.04B |
| FY 2024 | $889.2M | $84.04B | 34.1% | 51.4% | $5.7M | $16.52B |
| FY 2023 | $875.5M | $82.01B | — | — | $14.8M | $13.16B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ZUMZ // BETA —
PG // BETA 0.87